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The effect of a natural sesquiterpene ketone, 9,10-dehydrofukinone (DHF), on 16 
pathogenic Staphylococcus aureus and Pseudomonas aeruginosa strains isolated from 17 
chronic infectious processes, was the focus of the present study. Lipophilic DHF 18 
produced important antibacterial synergistic effects in association with ciprofloxacin 19 
(CPX) against two biofilm-forming strains of S. aureus HT1 (FIC = 0.21) and P. 20 
aeruginosa HT5 (FIC = 0.05). Hence, this mixture constitutes an excellent strategy to 21 
combat these biofilm-producing bacteria that overexpress drug efflux pumps as a 22 
resistance mechanism. Additionally, a substantial rise in beneficial Lactobacillus 23 
biofilm biomass was determined as a very significant finding of this association. 24 
Particularly, a non-pathogenic biofilm increment of 119% was quantified when the 25 
mixture was added to a probiotic L. acidophilus ATCC SD-5212 culture. A surface 26 
activity enhanced in 71% with respect to untreated L. acidophilus culture was also 27 
generated by the DHF and CPX association, and therefore a glycoprotein synthesis 28 
induction mediated by the mixture is discussed. The results obtained could help in the 29 
development of new selective antibiotics. From an ecological standpoint, the present 30 
study strongly suggests that DHF is a polyfunctional organic molecule produced with a 31 
high yield in Senecio punae that exerts a positive impact on a non-pathogenic plant 32 
bacterium L. plantarum CE105. 33 
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Resistance to antibiotics is an urgent public health problem, as new resistance 41 
mechanisms are emerging and are spreading worldwide, interfering with the treatment 42 
of common infectious illnesses. A growing list of infectious illness is becoming 43 
recalcitrant to therapy and extremely difficult to eradicate with traditional antibiotics. 44 
Tackling antibiotic resistance is a high priority for the World Health Organization.[1] 45 
Pseudomonas aeruginosa (Priority 1) and Staphylococcus aureus (Priority 2) are the 46 
most important resistant bacteria in need of urgent new treatments since they are 47 
involved in chronic infectious processes.  48 
Understanding the mechanisms involved in resistance to antibiotics is of 49 
importance both for the responsible use of antibiotics in practice, and for the 50 
development of new antibacterial drugs to circumvent resistance.[2] 51 
From an evolutionary perspective, bacteria use two major genetic strategies to adapt 52 
to the antibiotic “attack”: gene mutation, often associated with the mechanism of action 53 
of the compound, and acquisition of foreign DNA coding for resistance determinants 54 
through horizontal gene transfer.[3] Particularly, extrusion pumps provide an adaptation 55 
mechanism by which antibiotics are actively eliminated from bacterial cells and they are 56 
highly active in bacterial biofilms.[4]  57 
Biofilms are dynamic habitats that constantly evolve in response to environmental 58 
fluctuations and thereby constitute remarkable survival strategies for microorganisms.[5] 59 
These are a serious global health concern due to their abilities to tolerate antibiotics, 60 
host defense systems and other external stresses; therefore it contributes to persistent 61 
chronic infections. A biofilm comprises of the crammed bacterial population by an 62 
extracellular matrix that possesses bacterial secreted polymers such as 63 



















Reduced antibiotic susceptibility of bacteria in biofilms is understood to be due to a 65 
combination of poor antibiotic penetration, an altered microenvironment, adaptive 66 
responses, and the presence of bacterial persister cells.[7] Bacteria in biofilms show 67 
much greater resistance to antibiotics than their free-living counterparts. Hence, 68 
antibiotic-resistant bacteria are an obvious therapeutic objective, and the research of 69 
new antibiotic substances constitutes a potent tool for controlling the spread of resistant 70 
bacteria.[8][9] 71 
Natural products are promising resources for non-conventional antibiotic discovery 72 
that can attenuate or prevent bacterial resistance or virulence factor expression. Previous 73 
studies carried out in our laboratory demonstrated that small molecules with different 74 
sesquiterpene skeletons and functionalizations, isolated from native plants, exerted 75 
important effects against pathogenic biofilms and other key virulence factors controlled 76 
by quorum sensing mechanisms.[10 – 14] Certain sesquiterpene lactones enhanced the 77 
antimicrobial activity of traditional antibiotics making them effective against pathogenic 78 
bacteria, but without harm to beneficial bacteria with probiotic potentialities.[15]   79 
Lactobacilli, as bacterial symbionts that constitute the environmental and human 80 
microbiome, are considered as health-promoting bacteria due to their ability to produce 81 
various antimicrobial agents such as low molecular weight antimicrobials, bacteriocins, 82 
and adhesion inhibitors. Microbial surface active substances can interfere with pathogen 83 
adhesion on epithelial cells of intestinal and urogenital tracts, as well as on different 84 
surfaces and materials.[16] The antimicrobial and anti-adhesive properties of lactobacilli 85 
supernatants containing substances involved in quorum sensing and biofilm formation 86 
have been previously reported.[17][18]  87 
Continuing with our investigations, herein we report the inhibitory activity of the 88 



















tissues of several species of Senecio (Asteraceae, Senecioneae), against biofilm-90 
producing bacteria that overexpress drug efflux pumps, a fact determined by reactions 91 
with specific efflux pump inhibitors. Important synergistic interactions between DHF 92 
and ciprofloxacin on multidrug-resistant strains were also demonstrated, in agreement 93 
with our previous results.[19] The action of DHF on pathogenic and non-pathogenic 94 
bacteria was comparatively explored here. A significant surface activity was also 95 
noticed in the biofilm-forming Lactobacillus cultures in presence of DHF, and its 96 
probable ecological role and heath potential are hereby discussed for the first time. 97 
 
Results and Discussion 98 
Phytochemical analysis 99 
The diethyl ether extract contained a main volatile sesquiterpene ketone, 4β,5β-100 
eremophil-7(11)9-dien-8-one, also known as 9,10-dehydrofukinone, which was isolated 101 
as a pale yellow oil with a strong smell and unusual yield (2.1% related to the fresh 102 
plant material) by chromatographic techniques. IR, UV, EI-MS, 1H and 13C-NMR 103 
spectra were identical with previously reported data.[19 – 25] 104 
The isolation of DHF as the main volatile natural product in Senecio punae 105 
(Asteraceae, Senecioneae) might have chemotaxonomic implications. Indeed, DHF, a 106 
volatile molecule with great versatility to carry out many different biological activities, 107 
has been found in aerial parts of S. punae,[19] S. humillimus,[22] S. aureus,[23] and S. 108 
viridis var. viridis.[25] The occurrence of this bioactive sesquiterpene ketone in aerial 109 
tissues of various species of Senecio strongly suggests its functional role against biotic 110 




















Action of DHF and that of its mixture with ciprofloxacin on pathogenic and non-112 
pathogenic bacteria 113 
 
Pathogenic bacteria growth and biofilms 114 
DHF effects and those of its mixture with ciprofloxacin (CPX) on the bacterial growth 115 
and biofilm biomass of P. aeruginosa and S. aureus are shown in Figure 2. While the 116 
DHF antibacterial activity was mild against P. aeruginosa (MIC = 6 mg ml–1) and S. 117 
aureus (MIC = 1.5 mg ml–1), the mixture of DHF (23 µg ml–1) and CPX (0.25 µg ml–1) 118 
exerted important synergistic interactions in the antibacterial activity against hospital 119 
isolates of P. aeruginosa HT5 (FIC = 0.05) and S. aureus HMR1 (FIC = 0.21). 120 
S. aureus HT1 biofilm biomass after 24 h incubation in presence of DHF was 121 
significantly reduced by 68% at the MIC value (P ˂ 0.05) and its association (25 µg ml–122 
1) with CPX (0.25 µg ml–1) improved antibiofilm activity reaching 89% decrease of the 123 
biofilm biomass with respect to the control strain (without the addition of the mixture). 124 
It is important to note that DHF produced significant growth and biofilm 125 
diminution on a methicillin resistant S. aureus strain at a lower concentration than MIC 126 
(67% and 11%, respectively at 0.75 mg ml–1). In contrast, only the mixture exhibited a 127 
moderate reduction of the biofilm developed by P. aeruginosa HT5 (20%), as shown in 128 
Figure 2. Although DHF and its association with CPX were more active as 129 
antibacterial-antibiofilm agents against Gram (+) bacteria, this mixture showed a higher 130 
synergistic interaction on P. aeruginosa (FIC = 0.05). It is important to highlight that 131 
Gram negative pathogens generally exhibit a lower sensitivity to plant natural products 132 
than antibiotics as previously observed.[19][26][27]    133 
 



















Indole alkaloid reserpine, known efflux-pump inhibitor, associated with ciprofloxacin in 135 
lower concentrations than MIC, modified bacterial susceptibility to the antibiotic. 136 
The results shown in Table 1, revealed a significant drop in the MIC values of CPX 137 
ranging from 1.25 µg ml–1 to 0.25 µg ml–1 for S. aureus HT1, and from 5 µg ml–1 to 138 
0.25 µg ml–1 for P. aeruginosa wild-type strain HT5. Likewise, PAβN, known efflux-139 
pump inhibitor in Gram negative bacteria[28], increased the antibiotic activity on P. 140 
aeruginosa HT5. 141 
The bioassay performed with efflux pump inhibitors would prove the existence of 142 
efflux pumps as an antibiotic resistance mechanism in the selected bacteria. The results 143 
obtained were consistent with previous studies that reported that reserpine is a natural 144 
metabolite that blocks efflux pumps (NorA for fluoroquinolones) located in S. aureus 145 
membranes.[29] As has been well documented, plants are sources of potential resistance 146 
modifying agents and the involved compounds include different classes of natural 147 
products, such as: terpenes, flavones, flavonolignans, and porphyrins.[30 – 32] According 148 
to Gibbons,[33] common characteristics of all these agents appear to be the high degree 149 
of lipophilicity, a feature which is key for the interaction with membrane bound efflux 150 
proteins, and the ability to overcome membrane impermeability.  151 
A striking fact is that reserpine also modified P. aeruginosa HT5 susceptibility to 152 
CPX (Table 1), but in this case by a strong biofilm decrease (67%, Table 1) that 153 
improved the antibiotic entry into the bacterial cell. This fact agrees with a recent 154 
publication about the inhibitory effects of reserpine on P. aeruginosa quorum sensing 155 
mediated virulence factors and biofilm formation.[34] Additionally, PAβN, known 156 
efflux-pump inhibitor in Gram negative bacteria[28] allows us to corroborate the efflux 157 



















According to Kvist and coauthors,[4] biofilm formation has a positive correlation 159 
with the drug efflux pump activity. Thus, in the S. aureus HT1 strain, the probable 160 
attenuation of the protein pump could reduce the developed biofilm in relation to the 161 
control (Table 1). DHF (theoretical partition coefficient o/w of 4.814, and log P o/w = 162 
3.3135) shared a similar synergistic action with reserpine (Figure 2).  163 
 
Transmission electron microscopic findings  164 
Lipophilic DHF at non-inhibitory concentrations of 23 µg ml–1 exerts important 165 
alterations on P. aeruginosa HT5 cell wall and, in some cases, loss of wall structural 166 
integrity (Figure 3). The synergistic effects found between DHF and CPX would be 167 
brought about by the lipophilic natural product that causes the bacterial wall disruption, 168 
thus facilitating the passage and activity of the antibiotic. These findings provide more 169 
evidence that lipophilic compounds such as terpenes act as solvents causing a disruptive 170 
effect on the bacterial cell wall.[15][35]  171 
S. aureus HT1 ultrastructure did not show changes due to the action of DHF. 172 
Bacteria in division with preserved edges were observed both in treated and control 173 
samples in MET microphotographs (Figure 4). Also, DHF did not exert an antiadherent 174 
effect after 1 h of treatment, as explained in the Supplementary Information (see Figure 175 
S1). Therefore, these images and the DHF behaviour suggest that this sesquiterpene 176 
ketone could act as an attenuator of efflux pumps on S. aureus. Indeed, the presence of 177 
ciprofloxacin (pH 6.72 in MH medium) was evidenced by an extracellular pH decrease 178 
from 7.09 to 6.75 triggered by antibiotic, after 24 hours of incubation at 37 °C. This 179 
difference provides evidence of the extracellular localization of ciprofloxacin and 180 



















µg ml-1 exerted a full inhibition in presence of DHF at a sub-inhibitory concentration 182 
(23 µg ml-1). 183 
In light of the results obtained, the mode of action of DHF is substantially different 184 
for each of these strains. In P. aeruginosa HT5, this compound produces an alteration of 185 
the architecture of the cell wall, which would facilitate the diffusion of antibiotics into 186 
the cell. While in S. aureus HT1 DHF in the synergistic association would attenuate 187 
drug efflux pumps by increasing bacterial strain susceptibility to antibiotics, as do other 188 
lipophilic natural products.[29– 33] Thus, this association is effective in both cases. 189 
 
Non-target bacterial strains 190 
Growth and biofilms 191 
DHF at 23 µg ml–1 and its association with CPX at the inhibitory concentration 192 
against the pathogenic strains did not exert antibacterial effects against probiotic and 193 
indigenous strains isolated from different substrates of high-mountain biome (L. 194 
acidophilus ATCC SD5212, L. paracasei CE75 and L. plantarum CE105, respectively). 195 
Indeed, DHF at 23 µg ml–1 increased the growth from 13.31 ± 0.57 to 33.33 ± 2.76% for 196 
all Lactobacillus strains assayed, while the addition of the mixture produced a 197 
significant enhancement in biofilm biomass in all cultures (P ˂ 0.05), as shown in Table 198 
2.  199 
The most important effects on biofilm formation were observed in L. acidophilus 200 
ATCC SD-5212 with increments of 69 ± 2.37% for DHF at 23 µg ml–1 and 119 ± 1.53% 201 
for the mixture compared with the untreated control. DHF with a hundredfold higher 202 
concentration produced a steep increase of the bacterial biofilm (112 ± 1.00 and 112 ± 203 
2.72% for L. acidophilus and L. paracasei, respectively), and only the growths of L. 204 



















respectively. Lipophilic compounds are believed to be interspersed in bacterial 206 
membranes, altering their structure and properties. Bacteria then produce a hydrophilic 207 
exopolysaccharide that constitutes a physicochemical barrier to the intercalation, as an 208 
adaptation strategy to a hostile environment.[36] This phenomenon might be useful to 209 
explain the stimulation of biofilm formation produced by the natural stressor DHF. 210 
These results are consistent with those found in our earlier works.[15][19] This finding 211 
is very important since the biofilm developed by beneficial L. acidophilus strains would 212 
improve their tissue adhesion and their probiotic properties as previously published.[37 – 213 
39] 214 
Significant enhancement in surface activity of the Lactobacillus cultures  215 
Lactobacillus supernatants from the treated cultures with different amounts of DHF 216 
alone and mixed with CPX after 24 h of incubation generated higher halos in the oil 217 
spreading assay than the untreated culture supernatant (12 – 71%), which suggests a 218 
clear increase in surface activity, particularly in the association at lower concentrations 219 
of DHF and CPX. All supernatants were more effective than tween 80 (Figure 5). 220 
Nevertheless, DHF, DHF with CPX, and the solvent system of the samples previously 221 
added to the culture medium did not exert any activity by themselves. Therefore, the 222 
rise in Lactobacillus supernatant surface activity would be due to an increase in surface 223 
active substances by an induction to the biosynthesis thereof in the bacterial cultures.  224 
The surface activity makes Lactobacillus a promising source of anti-adhesive 225 
biomaterials with antimicrobial potential. Our result is in agreement with a previous 226 
investigation that reported on typical biosurfactants, named surlactin, that are 227 
glycoproteins,[17][40 – 42] released by Lactobacillus species and have  anti-adherent 228 
activity.[43] Indeed, a preliminary characterization by TLC and UV[44][45] of the surface 229 



















glycoproteins (data not shown). Nevertheless, further studies are necessary to identify 231 
these bacterial substances. 232 
 
Conclusions 233 
In conclusion, DHF in association with CPX represents an important strategy to 234 
combat biofilm forming pathogenic bacteria that overexpress drug efflux pumps as a 235 
resistance mechanism. This low-dose association of each substance did not inhibit the 236 
growth, and increased biofilm formation and anti-adherent activity of the beneficial 237 
Lactobacillus strains. This finding could help in the development of a new generation of 238 
antibiotics that are biofilm-promoters of the lactic acid bacteria present in the native 239 
microbiome. For this possible therapeutic application lipophilic DHF could be 240 
solubilized in polyethylene glycol (PEG). PEG is the most widely used polymer in the 241 
drug delivery field and classified as safe (GRAS) by the FDA. 242 
From an ecological standpoint, our exhaustive bibliographical revision[19 – 25] 243 
strongly suggests that DHF is a key marker of aroma and bioactivity in the volatile 244 
profile, produced with a high yield by many aromatic Senecio species, especially S. 245 
punae. In addition, this sesquiterpene ketone showed a positive impact on known 246 
beneficial bacteria, such as L. plantarum CE105, and the probiotic bacterium L. 247 
acidophilus ATCC SD-5212, as demonstrated in the present work.  248 
 
Experimental Section 249 
For thin layer chromatography (TLC), pre-coated SiO2 plates (Merck, Kieselgel 60 F) 250 
were employed. Spots on the plates were detected using Godin’s reagent followed by 251 
heating at 120 °C. SiO2 60 (Merck, 70 – 230 mesh) was used for column 252 



















spectrophotometer. FT-IR spectra were measured on a FT-Perkin Elmer-1600 254 
spectrophotometer. Optical rotations were measured on a HORIBA SEPA-300 high-255 
sensitive polarimeter with MeOH as a solvent. 1H- and 13C-NMR spectra were recorded 256 
on a Bruker 200 (200 MHz) spectrometer; d in ppm relative to Me4Si as internal 257 
standard, J in Hz. EI-MS was obtained on a Thermo Electron TraceTM GC Ultra 258 
coupled to a Thermo Electron Polaris Q ion trap mass spectrometer with a 30 m x 0.25 259 
mm id DB-5 MS column. The identification of DHF was based on computer matching 260 
with the NIST08 GC/MS library (USA), and since DHF is not commercially available, 261 
DHF used as a standard was obtained by exhaustive purification from S. punae aerial 262 
parts as already described.[19]  263 
Plant material 264 
S. punae Cabrera is an endemic high mountain shrub that grows in the Puna semi-desert 265 
region in the North of Argentina (3000-4600 m above sea level) where was collected 266 
during the flowering stage. A voucher specimen was deposited at the Herbarium of 267 
Fundación Miguel Lillo, Tucumán, Argentina (LIL 609967). 268 
Phytochemical study 269 
Only a few grams of fresh aerial parts were processed and extracted according to 270 
Rodriguez et al.
[19] The main volatile sesquiterpene ketone, known as 9,10-271 
dehydrofukinone was extracted with diethyl ether and isolated with an unusual yield 272 
(2.1% related to the fresh plant material) by routine chromatographic fractionations. IR, 273 
UV, EI-MS, 1H and 13C-NMR spectra were identical with previously reported data.[20 – 274 
25] 275 
4β,5β-eremophil-7(11)9-dien-8-one (DHF). [α]D = +131.97 (c 0.0167, MEOH). Rf = 276 
0.5 (SiO2, Hexane-AcOEt 95:5). TR: 40.35 min (DB-5, 30 m, 0.25 mm, ramp 277 




















UV/Vis λmax (MeOH) nm (log ε): 274 (1.39 sh), 248 (2.26), 208 (1.08). 
1H-NMR 279 
(CDCl3): 0.93 (s, Me(15)); 0.97 (s, Me(14)); 1.84 (s, Me(12)); 2.09 (s, Me(13)); 2.87(d, 280 
J = 13, H–C(6)); 5.74 (br s, C(9)).13C -NMR (CDCl3): 15.4 (C(15)); 15.9 (C(14)); 21.9 281 
(C(12)); 22.5 (C(13)); 26.4 (C(2)); 30.4 (C(1)); 32.5 (C(3)); 40.9 (C(4)); 41.8 (C(5)); 282 
42.4 (C(6)); 126.0 (C(9)); 128.1(C(7)); 142.1(C(11)); 168.7 (C(10)); 192.3 (C(8)). 283 
GC/MS (EI, 70 eV): 219 (100, M + H+); 218 (30, M+); 203 (14, M+ − Me); 189 (5, 219 284 
− 2 Me); 175 (9, M+ − Me – CO); 161 (12, 189 – CO); 147 (21, 175 − CH2=CH2).  285 
Microbiological analysis 286 
Pathogenic microorganisms 287 
Pseudomonas aeruginosa HT5, a strain resistant to several antibiotics (azithromycin 25 288 
µg, aztreonam 30 µg, ceftazidime 30 µg, cefepime 30 µg, imipenem 10 µg, meropenem 289 
10 µg, piperacillin-tazobactam 110 µg, gentamicin 30 µg, and ciprofloxacin 5 µg) was 290 
used.[46] The strain was grown for 24 h at 37 °C in Luria Bertani (LB) medium. Besides, 291 
Staphylococcus aureus HT1, a methicillin resistant strain (methicillin 30 µg, gentamicin 292 
30 µg, and azithromycin 5 µg) was also used. [47] This strain was grown in Müller 293 
Hinton (MH) medium for 24 h at 37 °C. Both biofilm-producing strains were isolated 294 
from chronic infections (Hospital isolates). 295 
Non-pathogenic microorganisms 296 
Lactobacillus paracasei subsp. paracasei CE75 and L. plantarum CE105 were isolated 297 
from regional cheeses and plants of high-mountain biome (respectively)[15][48], while L. 298 
acidophilus La-14 was a collection strain (ATCC SD-5212). These strains were grown 299 
in PTYg medium (15 g l–1 peptone, 10 g l–1 tryptone, 10 g l–1 yeast extract, and 5 g l–1 300 



















Bacterial growth  302 
An overnight culture (18 – 20 h) of the P. aeruginosa strain was diluted to reach an 303 
appropriate bacterial density (105 CFU ml–1) in a final volume of 200 µl. In the same 304 
way, the overnight culture of the S. aureus strain was diluted in MH medium. A volume 305 
of 190 µl was placed in each well of a microtiter polystyrene plate. Solutions containing 306 
different DHF amounts were prepared separately in DMSO/distilled and sterilized water 307 
(50:50), and 10 µl of each one were pipetted into the wells individually to obtain final 308 
concentrations of 23 – 6000 µg ml–1. After 24 h incubation at 37 °C, bacterial growth 309 
was measured at 600 nm (P. aeruginosa) and 560 nm (S. aureus), using a microtiter 310 
plate reader (Power Wave XS2, Biotek, VT, USA). A DMSO/water (50:50) solution 311 
added to the diluted culture was employed as growth control, and the antibiotic 312 
ciprofloxacin (CPX) was also incorporated into the bioassay, as a negative control. It 313 
was also associated with DHF to determine synergism. CPX acts on the bacterial DNA 314 
gyrase target and is a known biofilm inhibitor of P. aeruginosa strains.[12] Solubility 315 
controls for each substance and concentration were carried out in all assays. Absorbance 316 
values were subtracted from the average of the corresponding assay when there was 317 
turbidity. Synergistic effects of the DHF and CPX mixture against both strains were 318 
determined according to the following formula:  319 
FIC index = FICA + FICB = [A] / MICA + [B] / MICB, where “FICA, FICB” is 320 
the fractional inhibitory concentration of drug A and B, respectively; “MICA, MICB” is 321 
the minimum inhibitory concentration of drug A and B, respectively, and “[A], [B]” is 322 
the concentration of drug A and B, respectively. FIC index by checkerboard method is 323 
interpreted as follows: ≤ 0.5 synergy; > 0.5 and ≤ 4 additivity and > 4 antagonism.[49] 324 
Additionally, the effect of the mixture of DHF and CPX was proven on non- 325 



















Biofilm formation assay  327 
The biofilm quantification was done using a method based on a crystal violet stain 328 
according to a protocol previously reported[50] with several modifications.[46] 329 
Ciprofloxacin, a known biofilm inhibitor, was incorporated into the bioassay.[51] 330 
Effects of efflux pump inhibitors against pathogenic strains  331 
Alkaloid reserpine, a known efflux-pump inhibitor of multidrug-resistant bacteria was 332 
used to verify if bacteria modified their susceptibility to ciprofloxacin[29], as well as 333 
phenylalanine-arginine β-naphthylamide (PaβN). Hence, mixtures of ciprofloxacin at 334 
lower concentrations than MIC, and 20 µg ml–1 reserpine or 50 µg ml–1 PaβN that do 335 
not inhibit bacterial growth but block efflux pumps were evaluated. The second-336 
generation fluoroquinolone, ciprofloxacin, is the most often used antibiotic as the main 337 
reference substrate of NorA efflux pump assays.[9] 338 
The results of this bioassay would prove the occurrence of efflux pumps as an 339 
antibiotic resistance mechanism in the selected bacteria. Complementarily, biofilm 340 
formation inhibition and its correlation with the attenuation of drug efflux pump activity 341 
were also investigated in this work. 342 
Electron microscopic study 343 
In order to assess the effect of DHF, a suspension of each bacterium in MH or LB broth 344 
was exposed to a sub-inhibitory concentration (23 µg ml–1) of DHF for 24 h. A 345 
suspension of each microorganism was used as control. After exposure, aliquots of 346 
treatment and control suspensions were separated from the media and processed using 347 
routine techniques for transmission electron microscopy.  348 
For histological studies of samples (T and C) were fixed in Karnovsky's solution 349 
(formaldehyde 2.66%, glutaraldehyde 1.66%, and sodium phosphate buffer 0.1 M pH 350 



















osmium tetroxide (OsO4) to improve contrast. Preparations were dehydrated with 352 
increasing alcohol concentrations (30, 50, 70, 80, 85, 90 and 100%) and embedded in 353 
epoxy resin SPURR. Ultra-thin sections were made with an ultramicrotome, mounted 354 
on copper grids and contrasted with uranyl acetate and lead citrate. The samples were 355 
observed with a Zeiss EM109 (Carl Zeiss NTS GmbH, Oberkochen, Germany) 356 
transmission electron microscope (CIME-CONICET, Argentina). 357 
Lactobacillus supernatant surface activity 358 
Oil spreading assay  359 
The oil spreading assay is a rapid and highly sensitive method for surface-active 360 
substance detection[18][52] and it is a good choice to explore the surface activity of 361 
Lactobacillus supernatants (from control and treated cultures). 362 
For the assay, 20 µl of mineral oil were placed on a crystalliser (180 mm in 363 
diameter) with demineralized water (250 ml). Then, 10 µl of each free cell supernatant 364 
were gently put on the centre of the oil film. The diameters of clear halos (mm) 365 
visualized under visible light were measured in quintuplicate with respect to the control 366 
supernatant. Tween 80 was employed as a reference standard (positive control). The 367 
negative controls were the PTYg medium (without bacteria) and solutions of each 368 
compound assayed. 369 
Statistical Analysis 370 
Differences between means were evaluated by analysis of variance (ANOVA). For 371 
group comparison tests were used Tukey and subtle differences were used. In all 372 
statistical analyses, P values > 0.05 were not considered significant. Statistix 10 data 373 
analysis software for researches (2013) was used. 374 
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Figure 2. Effect of DHF and its mixture with CPX on growth and biofilms of P. aeruginosa and S. aureus. DHF: 9,10-
dehydrofukinone. CPX: Ciprofloxacin. All experiments showed significant differences with respect to controls (n = 8, P 





















































































































































































































































































































































Figure 3. Transmission electron microscopy microphotographs of P. aeruginosa. Control (top of figure) and treated 
cells with a sub-inhibitory concentration (23 µg ml–1) of DHF for 24 hours (bottom of figure) at a magnification of 














































Figure 4. Transmission electron microscopy MET microphotographs of S. aureus. Control (top of figure) and treated 
cells with a sub-inhibitory concentration (23 µg ml–1) of DHF for 24 hours (bottom of figure) at a magnification of 































Figure 5. Effect of DHF and its mixture with CPX on surface activity of the Lactobacillus supernatants. DHF: 9,10-
dehydrofukinone. CPX: Ciprofloxacin. All experiments showed significant differences with respect to controls (P < 
0.05). DHF, DHF with CPX, and the solvent system of the samples previously added to the culture medium (without 











































Table 1. Effects of efflux pump inhibitors and their mixtures with CPX against two 
pathogenic strains isolated from hospital  
 
Samples Bacterial strains 
 
 Pseudomonas aeruginosa HT5 
 









 [Means ± SD]  
Bacteria 0.903 ± 0.014 a 
 
1.644 ± 0.083 b 
 
1.532 ± 0.033 a 
 
2.949 ± 0.177 b 
 
CPX [MIC] 0.071 ± 0.010 e 0.091 ± 0.011 e  
 
0.082 ± 0.044 d 
 
0.092 ± 0.010 e 
 
Reserpine [20 µg ml-1] 0.814 ± 0.004 b 
 
3.412 ± 0.047 a 
 
1.449 ± 0.047 a 
 
3.299 ± 0.129 a 
 
Reserpine [20 µg ml-1] + 
CPX [0.25 µg ml-1] 
0.204 ± 0.006 d 
 
0.542 ± 0.012 d 0.269 ± 0.006 c 0.2893 ± 0.010 c 
 
PaβN [50 µg ml-1] 
 
0.876 ± 0.015 a 
- - - 
 
 
PaβN [50 µg ml-1] + CPX [0.25 µg ml-1] 
 
 
0.215 ± 0.005 d 
- - - 
CPX [0.25 µg ml-1] 0.6593 ± 0.011 c 
 
1.516 ± 0.010 c 1.042 ± 0.056 b 
 
2.731 ± 0.010 d 
CPX: Ciprofloxacin (MIC against P. aeruginosa HT5 = 7.5 µg ml-1; MIC against S. aureus HT1 = 1.25 µg ml-1). 
PaβN: Phenylalanine-arginine β-naphthylamide at 50 µg ml-1. (-): Not determined. Values within the same column 




















Table 2. Effect of the DHF and CPX mixture on Lactobacillus cultures  
 
Samples  Bacterial strains  
  
L. acidophilus ATCC 521 
 
 














 [Means ± SD]   


















DHF [23 µg ml-1] 1.745 ± 
0.010 a 
1.559 ± 





























DHF [23 µg ml-1] + CPX 











































DHF: 9,10-dehydrofukinone. CPX: Ciprofloxacin. (-): Not determined. Values within the same column with different 
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